glp-1 nejm Once-Weekly Mazdutide: Effective for Overweight and Obesity (GLORY-1 Study) SURMOUNT-1 (NEJM 2022) tested tirzepatide

That is the central asymmetry of this comparison: one drug has crossed the regulatory finish line, the other is still running the race

The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents

The "target maintenance dose" represents the dose likely needed to maintain similar metabolic effects

If you are looking for more context on safety, our glutathione safety guide is worth a look

In the present study, dietary L-carnitine supplementation increased the protein content of the whole body in the feeding trial, and did not affect the mRNA expressions of genes associated with protein and amino acid catabolism